OPCH Stock Recent News

Option Care (OPCH) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).

Option Care Health, Inc. (NASDAQ:OPCH ) Q1 2024 Earnings Conference Call April 23, 2024 8:30 AM ET Company Participants Mike Shapiro - Chief Financial Officer John Rademacher - President & Chief Executive Officer Conference Call Participants Jack Slevin - Jefferies David MacDonald - Truist Securities Lisa Gill - JPMorgan Matthew Larew - William Blair Pito Chickering - Deutsche Bank Michael Petusky - Barrington Research Joanna Gajuk - Bank of America Operator Good day and thank you for standing by. Welcome to the Option Care Health Q1 2024 Earnings Conference Call.

Option Care (OPCH) came out with quarterly earnings of $0.26 per share, beating the Zacks Consensus Estimate of $0.22 per share. This compares to earnings of $0.21 per share a year ago.

Option Care (OPCH) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.

BANNOCKBURN, Ill., April 04, 2024 (GLOBE NEWSWIRE) -- Option Care Health Inc. (“Option Care Health”) (NASDAQ: OPCH), the nation's largest independent provider of home and alternate site infusion services, today announced that the company will release results for its first quarter ended March 31, 2024 on Tuesday, April 23, 2024 before the market opens. In conjunction, the management team will host a conference call to review the results at 8:30 a.m. E.T. on the same day.

Option Care Health, Inc. (OPCH) Q4 2023 Earnings Call Transcript

Option Care (OPCH) came out with quarterly earnings of $0.32 per share, beating the Zacks Consensus Estimate of $0.29 per share. This compares to earnings of $0.26 per share a year ago.

Option Care (OPCH) could be a great choice for investors looking to make a profit from fundamentally strong stocks that are currently on the move. It is one of the several stocks that made it through our "Recent Price Strength" screen.

BANNOCKBURN, Ill., Jan. 22, 2024 (GLOBE NEWSWIRE) -- Option Care Health Inc. (“Option Care Health”) (NASDAQ: OPCH), the nation's largest independent provider of home and alternate site infusion services, today announced that the company will release results for its fourth quarter and full year ended December 31, 2023 on Thursday, February 22, 2024 before the market opens. In conjunction, the management team will host a conference call to review the results at 8:30 a.m. E.T. on the same day.

Option Care Health gives investors exposure to two healthcare megatrends: (i) the shift to healthcare delivery in the home; and (ii) the development of specialty pharmaceuticals. I believe OPCH holds a competitive moat, not only as the largest infusion provider in the US, but also due to its business model (predictable revenue and sticky client/customer base). I explain the street is highly conservative and project a ~150bps upside to FY24E EBITDA, and apply a ~15x multiple to that projection to arrive at my $38 2024 PT.